Literature DB >> 12176847

Immunology of vaccination.

P C L Beverley1.   

Abstract

An ideal vaccine is relatively easy to define, but few real vaccines approach the ideal and no vaccines exist for many organisms, for which a vaccine is the only realistic protective strategy in the foreseeable future. Many difficulties account for the failure to produce these vaccines. All micro-organisms deploy evasion mechanisms that interfere with effective immune responses and, for many organisms, it is not clear which immune responses provide effective protection. However, recent advances in methods for studying immune response to pathogens have provided a better understanding of immune mechanisms, including immunological memory, and led to the realisation that the initiation of immune responses is a key event requiring triggering through 'danger' signals. Based on these findings, the development of novel adjuvants, vectors and vaccine formulations allowing stimulation of optimal and prolonged protective immunity should lead to the introduction of vaccines for previously resistant organisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176847     DOI: 10.1093/bmb/62.1.15

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  16 in total

Review 1.  Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity.

Authors:  Mee Sook Park; Jin Il Kim; Sehee Park; Ilseob Lee; Man-Seong Park
Journal:  Immune Netw       Date:  2016-10-25       Impact factor: 6.303

Review 2.  Vitamin A supplementation and retinoic acid treatment in the regulation of antibody responses in vivo.

Authors:  A Catharine Ross
Journal:  Vitam Horm       Date:  2007       Impact factor: 3.421

3.  Small Wonders-The Use of Nanoparticles for Delivering Antigen.

Authors:  Aya Taki; Peter Smooker
Journal:  Vaccines (Basel)       Date:  2015-08-10

Review 4.  Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system.

Authors:  Aurélien Lathuilière; Nicolas Mach; Bernard L Schneider
Journal:  Int J Mol Sci       Date:  2015-05-08       Impact factor: 5.923

Review 5.  T-cell immunity to infection with dengue virus in humans.

Authors:  Daniela Weiskopf; Alessandro Sette
Journal:  Front Immunol       Date:  2014-03-07       Impact factor: 7.561

6.  Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles.

Authors:  Joseph A Rosenthal; Chung-Jr Huang; Anne M Doody; Tiffany Leung; Kaho Mineta; Danielle D Feng; Elizabeth C Wayne; Nozomi Nishimura; Cynthia Leifer; Matthew P DeLisa; Susana Mendez; David Putnam
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

Review 7.  Review of long term immunogenicity and tolerability of live hepatitis A vaccine.

Authors:  Nitin Shah; Mma Faridi; Monjori Mitra; Ashish Bavdekar; Archana Karadkhele; Gaurav Puppalwar; Rishi Jain
Journal:  Hum Vaccin Immunother       Date:  2020-04-03       Impact factor: 3.452

8.  Salmonella Typhimurium Adhesin OmpV Activates Host Immunity To Confer Protection against Systemic and Gastrointestinal Infection in Mice.

Authors:  Deepinder Kaur; Shraddha Gandhi; Arunika Mukhopadhaya
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

9.  Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice.

Authors:  Chui-Yoke Chin; Swee-Chen Tan; Sheila Nathan
Journal:  Front Cell Infect Microbiol       Date:  2012-06-15       Impact factor: 5.293

10.  Transgenic Bcl-3 slows T cell proliferation.

Authors:  Michael F J Bassetti; Janice White; John W Kappler; Philippa Marrack
Journal:  Int Immunol       Date:  2009-02-10       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.